| Year |
Citation |
Score |
| 2023 |
Yarmarkovich M, Marshall QF, Warrington JM, Premaratne R, Farrel A, Groff D, Li W, di Marco M, Runbeck E, Truong H, Toor JS, Tripathi S, Nguyen S, Shen H, Noel T, ... ... Eisenlohr L, et al. Targeting of intracellular oncoproteins with peptide-centric CARs. Nature. PMID 37938771 DOI: 10.1038/s41586-023-06706-0 |
0.353 |
|
| 2023 |
Dar AA, Kim DD, Gordon SM, Klinzing K, Rosen S, Guha I, Porter N, Ortega Y, Forsyth KS, Roof J, Fazelinia H, Spruce LA, Eisenlohr LC, Behrens EM, Oliver PM. c-Myc uses Cul4b to preserve genome integrity and promote antiviral CD8 T cell immunity. Nature Communications. 14: 7098. PMID 37925424 DOI: 10.1038/s41467-023-42765-7 |
0.355 |
|
| 2023 |
Hogan MJ, Maheshwari N, Begg BE, Nicastri A, Hedgepeth EJ, Muramatsu H, Pardi N, Miller MA, Reilly SP, Brossay L, Lynch KW, Ternette N, Eisenlohr LC. Cryptic MHC-E epitope from influenza elicits a potent cytolytic T cell response. Nature Immunology. 24: 1933-1946. PMID 37828378 DOI: 10.1038/s41590-023-01644-5 |
0.496 |
|
| 2022 |
Peauroi EM, Carro SD, Pei L, Reynoso GV, Hickman HD, Eisenlohr LC. The ectromelia virus virulence factor C15 facilitates early viral spread by inhibiting NK cell contact. Iscience. 25: 105510. PMID 36425759 DOI: 10.1016/j.isci.2022.105510 |
0.305 |
|
| 2022 |
Addison MM, Ellis GI, Leslie GJ, Zawadzky NB, Riley JL, Hoxie JA, Eisenlohr LC. HIV-1-Infected CD4 T Cells Present MHC Class II-Restricted Epitope via Endogenous Processing. Journal of Immunology (Baltimore, Md. : 1950). 209: 864-873. PMID 36130133 DOI: 10.4049/jimmunol.2200145 |
0.348 |
|
| 2021 |
Yarmarkovich M, Marshall QF, Warrington JM, Premaratne R, Farrel A, Groff D, Li W, di Marco M, Runbeck E, Truong H, Toor JS, Tripathi S, Nguyen S, Shen H, Noel T, ... ... Eisenlohr L, et al. Cross-HLA targeting of intracellular oncoproteins with peptide-centric CARs. Nature. PMID 34732890 DOI: 10.1038/s41586-021-04061-6 |
0.347 |
|
| 2021 |
Toulmin SA, Bhadiadra C, Paris AJ, Lin JH, Katzen J, Basil MC, Morrisey EE, Worthen GS, Eisenlohr LC. Type II alveolar cell MHCII improves respiratory viral disease outcomes while exhibiting limited antigen presentation. Nature Communications. 12: 3993. PMID 34183650 DOI: 10.1038/s41467-021-23619-6 |
0.374 |
|
| 2020 |
Laczkó D, Hogan MJ, Toulmin SA, Hicks P, Lederer K, Gaudette BT, Castaño D, Amanat F, Muramatsu H, Oguin TH, Ojha A, Zhang L, Mu Z, Parks R, Manzoni TB, ... ... Eisenlohr LC, et al. A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in Mice. Immunity. PMID 32783919 DOI: 10.1016/J.Immuni.2020.07.019 |
0.404 |
|
| 2020 |
Forsyth KS, Roy NH, Peauroi E, DeHaven BC, Wold ED, Hersperger AR, Burkhardt JK, Eisenlohr LC. Ectromelia-encoded virulence factor C15 specifically inhibits antigen presentation to CD4+ T cells post peptide loading. Plos Pathogens. 16: e1008685. PMID 32745153 DOI: 10.1371/Journal.Ppat.1008685 |
0.54 |
|
| 2020 |
Cosma GL, Lobby JL, Fay EJ, Siciliano NA, Langlois RA, Eisenlohr LC. Kinetically distinct processing pathways diversify the CD8 T cell response to a single viral epitope. Proceedings of the National Academy of Sciences of the United States of America. PMID 32719124 DOI: 10.1073/Pnas.2004372117 |
0.517 |
|
| 2020 |
Cho KJ, Ishido S, Eisenlohr LC, Roche PA. Activation of Dendritic Cells Alters the Mechanism of MHC Class II Antigen Presentation to CD4 T Cells. Journal of Immunology (Baltimore, Md. : 1950). PMID 31996461 DOI: 10.4049/Jimmunol.1901234 |
0.579 |
|
| 2019 |
Lang JF, Toulmin SA, Brida KL, Eisenlohr LC, Davidson BL. Standard screening methods underreport AAV-mediated transduction and gene editing. Nature Communications. 10: 3415. PMID 31363095 DOI: 10.1038/S41467-019-11321-7 |
0.309 |
|
| 2019 |
Forsyth KS, Addison MM, Eisenlohr LC. Recombinant Poxviruses: Versatile Tools for Immunological Assays. Methods in Molecular Biology (Clifton, N.J.). 1988: 217-248. PMID 31147943 DOI: 10.1007/978-1-4939-9450-2_16 |
0.468 |
|
| 2019 |
Cosma GL, Eisenlohr LC. Impact of epitope density on CD8+ T cell development and function. Molecular Immunology. PMID 30948189 DOI: 10.1016/J.Molimm.2019.03.010 |
0.538 |
|
| 2019 |
Forsyth KS, DeHaven B, Mendonca M, Paul S, Sette A, Eisenlohr LC. Poor Antigen Processing of Poxvirus Particles Limits CD4 T Cell Recognition and Impacts Immunogenicity of the Inactivated Vaccine. Journal of Immunology (Baltimore, Md. : 1950). PMID 30700590 DOI: 10.4049/Jimmunol.1801099 |
0.563 |
|
| 2018 |
Cosma G, Eisenlohr L. CD8 T-cell responses in vaccination: reconsidering targets and function in the context of chronic antigen stimulation. F1000research. 7. PMID 29770202 DOI: 10.12688/F1000Research.14115.1 |
0.464 |
|
| 2018 |
Pardi N, Hogan MJ, Naradikian MS, Parkhouse K, Cain DW, Jones L, Moody MA, Verkerke HP, Myles A, Willis E, LaBranche CC, Montefiori DC, Lobby JL, Saunders KO, Liao HX, ... ... Eisenlohr LC, et al. Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses. The Journal of Experimental Medicine. PMID 29739835 DOI: 10.1084/Jem.20171450 |
0.663 |
|
| 2018 |
Frey TR, Forsyth KS, Sheehan MM, De Haven BC, Pevarnik JG, Hand ES, Pizzorno MC, Eisenlohr LC, Hersperger AR. Ectromelia virus lacking the E3L ortholog is replication-defective and nonpathogenic but does induce protective immunity in a mouse strain susceptible to lethal mousepox. Virology. 518: 335-348. PMID 29602068 DOI: 10.1016/J.Virol.2018.03.016 |
0.388 |
|
| 2017 |
Tomov VT, Palko O, Lau CW, Pattekar A, Sun Y, Tacheva R, Bengsch B, Manne S, Cosma GL, Eisenlohr LC, Nice TJ, Virgin HW, Wherry EJ. Differentiation and Protective Capacity of Virus-Specific CD8(+) T Cells Suggest Murine Norovirus Persistence in an Immune-Privileged Enteric Niche. Immunity. PMID 29031786 DOI: 10.1016/J.Immuni.2017.09.017 |
0.479 |
|
| 2017 |
Babushok DV, Duke JL, Xie HM, Stanley N, Atienza J, Perdigones N, Nicholas P, Ferriola D, Li Y, Huang H, Ye W, Morrissette JJD, Kearns J, Porter DL, Podsakoff GM, ... Eisenlohr LC, et al. Somatic HLA Mutations Expose the Role of Class I-Mediated Autoimmunity in Aplastic Anemia and its Clonal Complications. Blood Advances. 1: 1900-1910. PMID 28971166 DOI: 10.1182/Bloodadvances.2017010918 |
0.409 |
|
| 2017 |
Veerappan Ganesan AP, Eisenlohr LC. The elucidation of non-classical MHC class II antigen processing through the study of viral antigens. Current Opinion in Virology. 22: 71-76. PMID 28081485 DOI: 10.1016/J.Coviro.2016.11.009 |
0.6 |
|
| 2017 |
Yarmarkovich M, Marco MD, Padovan O, Lobby J, Eisenlohr L, Monos D, Stevanovic S, Maris JM. Abstract 5824: MHC class I immunogenicity and novel tumor antigen discovery in neuroblastoma Cancer Research. 77: 5824-5824. DOI: 10.1158/1538-7445.Am2017-5824 |
0.426 |
|
| 2016 |
Norbury CC, Eisenlohr LC. Editorial overview: Antigen processing. Current Opinion in Immunology. PMID 27178764 DOI: 10.1016/J.Coi.2016.04.006 |
0.68 |
|
| 2016 |
Forsyth KS, Eisenlohr LC. Giving CD4+ T cells the slip: viral interference with MHC class II-restricted antigen processing and presentation. Current Opinion in Immunology. 40: 123-9. PMID 27115617 DOI: 10.1016/J.Coi.2016.03.003 |
0.573 |
|
| 2015 |
Miller MA, Ganesan AP, Luckashenak N, Mendonca M, Eisenlohr LC. Endogenous antigen processing drives the primary CD4(+) T cell response to influenza. Nature Medicine. 21: 1216-22. PMID 26413780 DOI: 10.1038/Nm.3958 |
0.607 |
|
| 2015 |
Sponton L, Cosma G, Mendonca M, Giovarelli M, Eisenlohr LC. Abstract 1294: Identification of tumor-specific antigens associated with RET/PTC3 expression Cancer Research. 75: 1294-1294. DOI: 10.1158/1538-7445.Am2015-1294 |
0.473 |
|
| 2014 |
Siciliano NA, Hersperger AR, Lacuanan AM, Xu RH, Sidney J, Sette A, Sigal LJ, Eisenlohr LC. Impact of distinct poxvirus infections on the specificities and functionalities of CD4+ T cell responses. Journal of Virology. 88: 10078-91. PMID 24965457 DOI: 10.1128/Jvi.01150-14 |
0.517 |
|
| 2014 |
Hersperger AR, Siciliano NA, DeHaven BC, Snook AE, Eisenlohr LC. Epithelial immunization induces polyfunctional CD8+ T cells and optimal mousepox protection. Journal of Virology. 88: 9472-5. PMID 24899206 DOI: 10.1128/Jvi.01464-14 |
0.456 |
|
| 2014 |
Goodenough E, Robinson TM, Zook MB, Flanigan KM, Atkins JF, Howard MT, Eisenlohr LC. Cryptic MHC class I-binding peptides are revealed by aminoglycoside-induced stop codon read-through into the 3' UTR. Proceedings of the National Academy of Sciences of the United States of America. 111: 5670-5. PMID 24706797 DOI: 10.1073/Pnas.1402670111 |
0.769 |
|
| 2014 |
Davies ML, Sei JJ, Siciliano NA, Xu RH, Roscoe F, Sigal LJ, Eisenlohr LC, Norbury CC. MyD88-dependent immunity to a natural model of vaccinia virus infection does not involve Toll-like receptor 2. Journal of Virology. 88: 3557-67. PMID 24403581 DOI: 10.1128/Jvi.02776-13 |
0.679 |
|
| 2014 |
Walline CC, Deffit SN, Wang N, Guindon LM, Crotzer VL, Liu J, Hollister K, Eisenlohr LC, Brutkiewicz RR, Kaplan MH, Blum JS. Virus-encoded ectopic CD74 enhances poxvirus vaccine efficacy. Immunology. 141: 531-9. PMID 24205828 DOI: 10.1111/Imm.12210 |
0.724 |
|
| 2013 |
Miller MA, Ganesan AP, Eisenlohr LC. Toward a Network Model of MHC Class II-Restricted Antigen Processing. Frontiers in Immunology. 4: 464. PMID 24379819 DOI: 10.3389/Fimmu.2013.00464 |
0.553 |
|
| 2013 |
Siciliano NA, Huang L, Eisenlohr LC. Recombinant poxviruses: versatile tools for immunological assays. Methods in Molecular Biology (Clifton, N.J.). 960: 219-45. PMID 23329491 DOI: 10.1007/978-1-62703-218-6_18 |
0.547 |
|
| 2013 |
Eisenlohr LC. Alternative generation of MHC class II-restricted epitopes: not so exceptional? Molecular Immunology. 55: 169-71. PMID 23200635 DOI: 10.1016/J.Molimm.2012.10.020 |
0.573 |
|
| 2013 |
Luckashenak N, Eisenlohr LC. Dendritic Cells: Antigen Processing and Presentation Cancer Immunotherapy: Immune Suppression and Tumor Growth: Second Edition. 55-70. DOI: 10.1016/B978-0-12-394296-8.00005-1 |
0.399 |
|
| 2012 |
Fang M, Siciliano NA, Hersperger AR, Roscoe F, Hu A, Ma X, Shamsedeen AR, Eisenlohr LC, Sigal LJ. Perforin-dependent CD4+ T-cell cytotoxicity contributes to control a murine poxvirus infection. Proceedings of the National Academy of Sciences of the United States of America. 109: 9983-8. PMID 22665800 DOI: 10.1073/Pnas.1202143109 |
0.489 |
|
| 2012 |
Hersperger AR, Siciliano NA, Eisenlohr LC. Comparable polyfunctionality of ectromelia virus- and vaccinia virus-specific murine T cells despite markedly different in vivo replication and pathogenicity. Journal of Virology. 86: 7298-309. PMID 22532670 DOI: 10.1128/Jvi.00038-12 |
0.497 |
|
| 2012 |
Luckashenak N, Miller M, Eisenlohr L. Relative contribution of endogenous epitopes to the H-2b-restricted anti-influenza CD4+ T cell response Molecular Immunology. 51: 13. DOI: 10.1016/J.Molimm.2012.02.031 |
0.447 |
|
| 2011 |
Eisenlohr LC, Luckashenak N, Apcher S, Miller MA, Sinnathamby G. Beyond the classical: influenza virus and the elucidation of alternative MHC class II-restricted antigen processing pathways. Immunologic Research. 51: 237-48. PMID 22101673 DOI: 10.1007/S12026-011-8257-3 |
0.61 |
|
| 2011 |
Comber JD, Robinson TM, Siciliano NA, Snook AE, Eisenlohr LC. Functional macroautophagy induction by influenza A virus without a contribution to major histocompatibility complex class II-restricted presentation. Journal of Virology. 85: 6453-63. PMID 21525345 DOI: 10.1128/Jvi.02122-10 |
0.821 |
|
| 2011 |
Huang L, Kuhls MC, Eisenlohr LC. Hydrophobicity as a driver of MHC class I antigen processing. The Embo Journal. 30: 1634-44. PMID 21378750 DOI: 10.1038/Emboj.2011.62 |
0.469 |
|
| 2011 |
Huang L, Marvin JM, Tatsis N, Eisenlohr LC. Cutting Edge: Selective role of ubiquitin in MHC class I antigen presentation. Journal of Immunology (Baltimore, Md. : 1950). 186: 1904-8. PMID 21239720 DOI: 10.4049/Jimmunol.1003411 |
0.423 |
|
| 2010 |
Testa JS, Apcher GS, Comber JD, Eisenlohr LC. Exosome-driven antigen transfer for MHC class II presentation facilitated by the receptor binding activity of influenza hemagglutinin. Journal of Immunology (Baltimore, Md. : 1950). 185: 6608-16. PMID 21048109 DOI: 10.4049/Jimmunol.1001768 |
0.748 |
|
| 2009 |
Snook AE, Li P, Stafford BJ, Faul EJ, Huang L, Birbe RC, Bombonati A, Schulz S, Schnell MJ, Eisenlohr LC, Waldman SA. Lineage-specific T-cell responses to cancer mucosa antigen oppose systemic metastases without mucosal inflammatory disease. Cancer Research. 69: 3537-44. PMID 19351847 DOI: 10.1158/0008-5472.Can-08-3386 |
0.417 |
|
| 2008 |
Snook AE, Huang L, Schulz S, Eisenlohr LC, Waldman SA. Cytokine adjuvanation of therapeutic anti-tumor immunity targeted to cancer mucosa antigens. Clinical and Translational Science. 1: 263-4. PMID 19956776 DOI: 10.1111/J.1752-8062.2008.00054.X |
0.35 |
|
| 2008 |
Snook AE, Stafford BJ, Li P, Tan G, Huang L, Birbe R, Schulz S, Schnell MJ, Thakur M, Rothstein JL, Eisenlohr LC, Waldman SA. Guanylyl cyclase C-induced immunotherapeutic responses opposing tumor metastases without autoimmunity. Journal of the National Cancer Institute. 100: 950-61. PMID 18577748 DOI: 10.1093/Jnci/Djn178 |
0.398 |
|
| 2008 |
Plesa G, Snook AE, Waldman SA, Eisenlohr LC. Derivation and fluidity of acutely induced dysfunctional CD8+ T cells. Journal of Immunology (Baltimore, Md. : 1950). 180: 5300-8. PMID 18390711 DOI: 10.4049/Jimmunol.180.8.5300 |
0.421 |
|
| 2007 |
Snook AE, Stafford BJ, Eisenlohr LC, Rothstein JL, Waldman SA. Mucosally restricted antigens as novel immunological targets for antitumor therapy. Biomarkers in Medicine. 1: 187-202. PMID 20477468 DOI: 10.2217/17520363.1.1.187 |
0.317 |
|
| 2007 |
Snook AE, Eisenlohr LC, Rothstein JL, Waldman SA. Cancer mucosa antigens as a novel immunotherapeutic class of tumor-associated antigen. Clinical Pharmacology and Therapeutics. 82: 734-9. PMID 17898707 DOI: 10.1038/Sj.Clpt.6100369 |
0.368 |
|
| 2007 |
Eisenlohr LC, Huang L, Golovina TN. Rethinking peptide supply to MHC class I molecules. Nature Reviews. Immunology. 7: 403-10. PMID 17457346 DOI: 10.1038/Nri2077 |
0.446 |
|
| 2006 |
Tang J, Murtadha M, Schnell M, Eisenlohr LC, Hooper J, Flomenberg P. Human T-cell responses to vaccinia virus envelope proteins. Journal of Virology. 80: 10010-20. PMID 17005679 DOI: 10.1128/Jvi.00601-06 |
0.487 |
|
| 2006 |
Plesa G, McKenna PM, Schnell MJ, Eisenlohr LC. Immunogenicity of cytopathic and noncytopathic viral vectors. Journal of Virology. 80: 6259-66. PMID 16775313 DOI: 10.1128/Jvi.00084-06 |
0.48 |
|
| 2006 |
Zook MB, Howard MT, Sinnathamby G, Atkins JF, Eisenlohr LC. Epitopes derived by incidental translational frameshifting give rise to a protective CTL response. Journal of Immunology (Baltimore, Md. : 1950). 176: 6928-34. PMID 16709853 DOI: 10.4049/Jimmunol.176.11.6928 |
0.454 |
|
| 2006 |
Tang J, Olive M, Pulmanausahakul R, Schnell M, Flomenberg N, Eisenlohr L, Flomenberg P. Human CD8+ cytotoxic T cell responses to adenovirus capsid proteins. Virology. 350: 312-22. PMID 16499941 DOI: 10.1016/J.Virol.2006.01.024 |
0.483 |
|
| 2006 |
Wherry EJ, Golovina TN, Morrison SE, Sinnathamby G, McElhaugh MJ, Shockey DC, Eisenlohr LC. Re-evaluating the generation of a "proteasome-independent" MHC class I-restricted CD8 T cell epitope. Journal of Immunology (Baltimore, Md. : 1950). 176: 2249-61. PMID 16455981 DOI: 10.4049/Jimmunol.176.4.2249 |
0.39 |
|
| 2005 |
Eisenlohr LC, Rothstein JL. Antigen processing and presentation. Cancer Treatment and Research. 123: 3-36. PMID 16211864 |
0.3 |
|
| 2005 |
Lefebvre JM, Haks MC, Carleton MO, Rhodes M, Sinnathamby G, Simon MC, Eisenlohr LC, Garrett-Sinha LA, Wiest DL. Enforced expression of Spi-B reverses T lineage commitment and blocks beta-selection. Journal of Immunology (Baltimore, Md. : 1950). 174: 6184-94. PMID 15879115 DOI: 10.4049/Jimmunol.174.10.6184 |
0.388 |
|
| 2005 |
Golovina TN, Morrison SE, Eisenlohr LC. The impact of misfolding versus targeted degradation on the efficiency of the MHC class I-restricted antigen processing. Journal of Immunology (Baltimore, Md. : 1950). 174: 2763-9. PMID 15728485 DOI: 10.4049/Jimmunol.174.5.2763 |
0.401 |
|
| 2005 |
Tewari MK, Sinnathamby G, Rajagopal D, Eisenlohr LC. A cytosolic pathway for MHC class II-restricted antigen processing that is proteasome and TAP dependent. Nature Immunology. 6: 287-94. PMID 15711549 DOI: 10.1038/Ni1171 |
0.559 |
|
| 2005 |
Tewari MK, Sinnathamby G, Rajagopal D, Eisenlohr LC. Erratum: Corrigendum: A cytosolic pathway for MHC class II–restricted antigen processing that is proteasome and TAP dependent Nature Immunology. 6: 420-420. DOI: 10.1038/Ni0405-420 |
0.331 |
|
| 2004 |
Tang J, Olive M, Champagne K, Flomenberg N, Eisenlohr L, Hsu S, Flomenberg P. Adenovirus hexon T-cell epitope is recognized by most adults and is restricted by HLA DP4, the most common class II allele. Gene Therapy. 11: 1408-15. PMID 15269714 DOI: 10.1038/Sj.Gt.3302316 |
0.533 |
|
| 2004 |
Sinnathamby G, Maric M, Cresswell P, Eisenlohr LC. Differential requirements for endosomal reduction in the presentation of two H2-E(d)-restricted epitopes from influenza hemagglutinin. Journal of Immunology (Baltimore, Md. : 1950). 172: 6607-14. PMID 15153475 DOI: 10.4049/Jimmunol.172.11.6607 |
0.368 |
|
| 2004 |
Tatsis N, Sinnathamby G, Eisenlohr LC. Vaccinia virus as a tool for immunologic studies. Methods in Molecular Biology (Clifton, N.J.). 269: 267-88. PMID 15114021 DOI: 10.1385/1-59259-789-0:267 |
0.542 |
|
| 2003 |
Spierings E, Brickner AG, Caldwell JA, Zegveld S, Tatsis N, Blokland E, Pool J, Pierce RA, Mollah S, Shabanowitz J, Eisenlohr LC, van Veelen P, Ossendorp F, Hunt DF, Goulmy E, et al. The minor histocompatibility antigen HA-3 arises from differential proteasome-mediated cleavage of the lymphoid blast crisis (Lbc) oncoprotein. Blood. 102: 621-9. PMID 12663445 DOI: 10.1182/Blood-2003-01-0260 |
0.54 |
|
| 2003 |
Sinnathamby G, Eisenlohr LC. Presentation by recycling MHC class II molecules of an influenza hemagglutinin-derived epitope that is revealed in the early endosome by acidification. Journal of Immunology (Baltimore, Md. : 1950). 170: 3504-13. PMID 12646611 DOI: 10.4049/Jimmunol.170.7.3504 |
0.477 |
|
| 2003 |
Powell DJ, Eisenlohr LC, Rothstein JL. A thyroid tumor-specific antigen formed by the fusion of two self proteins. Journal of Immunology (Baltimore, Md. : 1950). 170: 861-9. PMID 12517951 DOI: 10.4049/Jimmunol.170.2.861 |
0.377 |
|
| 2002 |
Olive M, Eisenlohr L, Flomenberg N, Hsu S, Flomenberg P. The adenovirus capsid protein hexon contains a highly conserved human CD4+ T-cell epitope. Human Gene Therapy. 13: 1167-78. PMID 12133270 DOI: 10.1089/104303402320138952 |
0.543 |
|
| 2002 |
Wherry EJ, McElhaugh MJ, Eisenlohr LC. Generation of CD8(+) T cell memory in response to low, high, and excessive levels of epitope. Journal of Immunology (Baltimore, Md. : 1950). 168: 4455-61. PMID 11970989 DOI: 10.4049/Jimmunol.168.9.4455 |
0.423 |
|
| 2002 |
Golovina TN, Wherry EJ, Bullock TN, Eisenlohr LC. Efficient and qualitatively distinct MHC class I-restricted presentation of antigen targeted to the endoplasmic reticulum. Journal of Immunology (Baltimore, Md. : 1950). 168: 2667-75. PMID 11884431 DOI: 10.4049/Jimmunol.168.6.2667 |
0.372 |
|
| 2002 |
Olive M, Eisenlohr LC, Flomenberg P. Quantitative analysis of adenovirus-specific CD4+ T-cell responses from healthy adults. Viral Immunology. 14: 403-13. PMID 11792069 DOI: 10.1089/08828240152716646 |
0.451 |
|
| 2001 |
Pierce RA, Field ED, Mutis T, Golovina TN, Von Kap-Herr C, Wilke M, Pool J, Shabanowitz J, Pettenati MJ, Eisenlohr LC, Hunt DF, Goulmy E, Engelhard VH. The HA-2 minor histocompatibility antigen is derived from a diallelic gene encoding a novel human class I myosin protein. Journal of Immunology (Baltimore, Md. : 1950). 167: 3223-30. PMID 11544309 DOI: 10.4049/Jimmunol.167.6.3223 |
0.477 |
|
| 2001 |
Brickner AG, Warren EH, Caldwell JA, Akatsuka Y, Golovina TN, Zarling AL, Shabanowitz J, Eisenlohr LC, Hunt DF, Engelhard VH, Riddell SR. The immunogenicity of a new human minor histocompatibility antigen results from differential antigen processing. The Journal of Experimental Medicine. 193: 195-206. PMID 11148223 DOI: 10.1084/Jem.193.2.195 |
0.534 |
|
| 2001 |
Wherry EJ, Rajagopal D, Eisenlohr LC. Use of vaccinia virus expression vectors to investigate antigen processing and presentation Methods in Molecular Biology (Clifton, N.J.). 156: 89-109. PMID 11068753 DOI: 10.1385/1-59259-062-4:89 |
0.439 |
|
| 2000 |
Grandea AG, Golovina TN, Hamilton SE, Sriram V, Spies T, Brutkiewicz RR, Harty JT, Eisenlohr LC, Van Kaer L. Impaired assembly yet normal trafficking of MHC class I molecules in Tapasin mutant mice. Immunity. 13: 213-22. PMID 10981964 DOI: 10.1016/S1074-7613(00)00021-2 |
0.727 |
|
| 2000 |
Trotta R, Fettucciari K, Azzoni L, Abebe B, Puorro KA, Eisenlohr LC, Perussia B. Differential role of p38 and c-Jun N-terminal kinase 1 mitogen-activated protein kinases in NK cell cytotoxicity Journal of Immunology. 165: 1782-1789. PMID 10925255 DOI: 10.4049/Jimmunol.165.4.1782 |
0.319 |
|
| 2000 |
Mastrangelo MJ, Eisenlohr LC, Gomella L, Lattime EC. Poxvirus vectors: orphaned and underappreciated. The Journal of Clinical Investigation. 105: 1031-4. PMID 10772644 DOI: 10.1172/Jci9819 |
0.31 |
|
| 1999 |
Mastrangelo MJ, Maguire HC, Eisenlohr LC, Laughlin CE, Monken CE, McCue PA, Kovatich AJ, Lattime EC. Intratumoral recombinant GM-CSF-encoding virus as gene therapy in patients with cutaneous melanoma. Cancer Gene Therapy. 6: 409-422. PMID 10505851 DOI: 10.1038/Sj.Cgt.7700066 |
0.333 |
|
| 1997 |
Sato T, Bullock TN, Eisenlohr LC, Mastrangelo MJ, Berd D. Dinitrophenyl-modified autologous melanoma vaccine induces a T cell response to hapten-modified, melanoma peptides. Clinical Immunology and Immunopathology. 85: 265-72. PMID 9400626 DOI: 10.1006/Clin.1997.4419 |
0.472 |
|
| 1997 |
Yellen-Shaw AJ, Laughlin CE, Metrione RM, Eisenlohr LC. Murine transporter associated with antigen presentation (TAP) preferences influence class I-restricted T cell responses. The Journal of Experimental Medicine. 186: 1655-62. PMID 9362526 DOI: 10.1084/Jem.186.10.1655 |
0.526 |
|
| 1997 |
Bullock TN, Patterson AE, Franlin LL, Notidis E, Eisenlohr LC. Initiation codon scanthrough versus termination codon readthrough demonstrates strong potential for major histocompatibility complex class I-restricted cryptic epitope expression. The Journal of Experimental Medicine. 186: 1051-8. PMID 9314554 DOI: 10.1084/Jem.186.7.1051 |
0.445 |
|
| 1997 |
Bacik I, Snyder HL, Antón LC, Russ G, Chen W, Bennink JR, Urge L, Otvos L, Dudkowska B, Eisenlohr L, Yewdell JW. Introduction of a glycosylation site into a secreted protein provides evidence for an alternative antigen processing pathway: transport of precursors of major histocompatibility complex class I-restricted peptides from the endoplasmic reticulum to the cytosol. The Journal of Experimental Medicine. 186: 479-87. PMID 9254646 DOI: 10.1084/Jem.186.4.479 |
0.714 |
|
| 1996 |
Bullock TN, Eisenlohr LC. Ribosomal scanning past the primary initiation codon as a mechanism for expression of CTL epitopes encoded in alternative reading frames. The Journal of Experimental Medicine. 184: 1319-29. PMID 8879204 DOI: 10.1084/Jem.184.4.1319 |
0.494 |
|
| 1994 |
Wysocka M, Eisenlohr LC, Otvos L, Horowitz D, Yewdell JW, Bennink JR, Hackett CJ. Identification of overlapping class I and class II H-2d-restricted T cell determinants of influenza virus N1 neuraminidase that require infectious virus for presentation. Virology. 201: 86-94. PMID 7513927 DOI: 10.1006/Viro.1994.1268 |
0.697 |
|
| 1993 |
Yewdell JW, Esquivel F, Arnold D, Spies T, Eisenlohr LC, Bennink JR. Presentation of numerous viral peptides to mouse major histocompatibility complex (MHC) class I-restricted T lymphocytes is mediated by the human MHC-encoded transporter or by a hybrid mouse-human transporter. The Journal of Experimental Medicine. 177: 1785-90. PMID 8496691 DOI: 10.1084/Jem.177.6.1785 |
0.788 |
|
| 1993 |
Yewdell JW, Anderson R, Cox JH, Eisenlohr LC, Esquivel F, Lapham C, Restifo NP, Bennink JR. The multiple uses of viruses for studying antigen processing Seminars in Virology. 4: 109-116. DOI: 10.1006/Smvy.1993.1005 |
0.785 |
|
| 1992 |
Eisenlohr LC, Yewdell JW, Bennink JR. Flanking sequences influence the presentation of an endogenously synthesized peptide to cytotoxic T lymphocytes. The Journal of Experimental Medicine. 175: 481-7. PMID 1732413 DOI: 10.1084/Jem.175.2.481 |
0.634 |
|
| 1992 |
Eisenlohr LC, Yewdell JW, Bennink JR. A transient transfection system for identifying biosynthesized proteins processed and presented to class I MHC restricted T lymphocytes. Journal of Immunological Methods. 154: 131-8. PMID 1401939 DOI: 10.1016/0022-1759(92)90220-N |
0.697 |
|
| 1991 |
Hackett CJ, Horowitz D, Wysocka M, Eisenlohr LC. Immunogenic peptides of influenza virus subtype N1 neuraminidase identify a T-cell determinant used in class II major histocompatibility complex-restricted responses to infectious virus. Journal of Virology. 65: 672-6. PMID 1898970 DOI: 10.1128/Jvi.65.2.672-676.1991 |
0.518 |
|
| 1990 |
Hackett CJ, Eisenlohr LC. Virus entry and antigen biosynthesis in the processing and presentation of class-II MHC-restricted T-cell determinants of influenza virus. Immunologic Research. 9: 103-14. PMID 2140852 DOI: 10.1007/Bf02918201 |
0.513 |
|
| 1990 |
Cox JH, Yewdell JW, Eisenlohr LC, Johnson PR, Bennink JR. Antigen presentation requires transport of MHC class I molecules from the endoplasmic reticulum. Science (New York, N.Y.). 247: 715-8. PMID 2137259 DOI: 10.1126/Science.2137259 |
0.669 |
|
| 1989 |
Eisenlohr LC, Hackett CJ. Class II major histocompatibility complex-restricted T cells specific for a virion structural protein that do not recognize exogenous influenza virus. Evidence that presentation of labile T cell determinants is favored by endogenous antigen synthesis. The Journal of Experimental Medicine. 169: 921-31. PMID 2784481 DOI: 10.1084/Jem.169.3.921 |
0.536 |
|
| 1987 |
Eisenlohr LC, Gerhard W, Hackett CJ. Role of receptor-binding activity of the viral hemagglutinin molecule in the presentation of influenza virus antigens to helper T cells. Journal of Virology. 61: 1375-83. PMID 2952806 DOI: 10.1128/Jvi.61.5.1375-1383.1987 |
0.715 |
|
| Show low-probability matches. |